litlas
ログインアカウント作成

Ken Yamaguchi

1977–2025 年に発表

171
論文数
25,666
被引用数
91
h 指数
160
i10 指数

被引用数

Ken Yamaguchi の年別被引用数1978 年: 被引用 2 件1979 年: 被引用 2 件1980 年: 被引用 1 件1981 年: 被引用 1 件1983 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 2 件1986 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 6 件1991 年: 被引用 11 件1992 年: 被引用 11 件1993 年: 被引用 5 件1994 年: 被引用 8 件1995 年: 被引用 7 件1996 年: 被引用 11 件1997 年: 被引用 14 件1998 年: 被引用 17 件1999 年: 被引用 25 件2000 年: 被引用 39 件2001 年: 被引用 41 件2002 年: 被引用 35 件2003 年: 被引用 54 件2004 年: 被引用 57 件2005 年: 被引用 96 件2006 年: 被引用 108 件2007 年: 被引用 118 件2008 年: 被引用 141 件2009 年: 被引用 165 件2010 年: 被引用 182 件2011 年: 被引用 206 件2012 年: 被引用 192 件2013 年: 被引用 218 件2014 年: 被引用 245 件2015 年: 被引用 262 件2016 年: 被引用 259 件2017 年: 被引用 290 件2018 年: 被引用 257 件2019 年: 被引用 910 件2020 年: 被引用 867 件2021 年: 被引用 819 件2022 年: 被引用 624 件2023 年: 被引用 473 件2024 年: 被引用 746 件2025 年: 被引用 312 件2026 年: 被引用 8 件1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,599 件、この内訳の 29.9%中国: 引用元論文 1,394 件、この内訳の 16.1%日本: 引用元論文 516 件、この内訳の 5.9%イギリス: 引用元論文 387 件、この内訳の 4.5%イタリア: 引用元論文 343 件、この内訳の 4%ドイツ: 引用元論文 296 件、この内訳の 3.4%カナダ: 引用元論文 295 件、この内訳の 3.4%韓国: 引用元論文 278 件、この内訳の 3.2%フランス: 引用元論文 242 件、この内訳の 2.8%オーストラリア: 引用元論文 214 件、この内訳の 2.5%スペイン: 引用元論文 177 件、この内訳の 2%スイス: 引用元論文 169 件、この内訳の 1.9%
0%29.9%その他 20.4%

機関

分野

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology15%
  • Immunology and Microbiology9.3%
  • Engineering1.9%
  • Neuroscience1%
  • Computer Science0.3%
  • その他1.1%

トピック

  • Shoulder Injury and Treatment9%
  • Cancer Immunotherapy and Biomarkers8.1%
  • Shoulder and Clavicle Injuries4.9%
  • Immunotherapy and Immune Responses3.8%
  • Immune Cell Function and Interaction3.5%
  • Immune cells in cancer2.7%
  • その他68%

共著者

全論文

検索で開く
  1. Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

    著者: Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Yuko Hosoe, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi - Journal of Clinical Oncology 2015 被引用: 1,192

  2. Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition

    著者: Mana Taki, Kaoru Abiko, Masayo Ukita, Ryusuke Murakami, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai - Clinical Cancer Research 2021 被引用: 360

  3. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

    著者: Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Naoki Horikawa, Ryusuke Murakami, Ken Yamaguchi, Yumiko Yoshioka, Tsukasa Baba, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2015 被引用: 709

  4. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

    著者: Masayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi, Koji Yamanoi, Shiro Takamatsu, Akihiko Ueda, Haruka Suzuki, Yuko Hosoe, Yoko Furutake, Mana Taki, Kaoru Abiko, Ken Yamaguchi, Hidekatsu Nakai, Tsukasa Baba, Noriomi Matsumura, Akihiko Yoshizawa, Hideki Ueno, Masaki Mandai - JCI Insight 2022 被引用: 190

  5. The Outcome and Repair Integrity of Completely Arthroscopically Repaired Large and Massive Rotator Cuff Tears

    著者: Leesa M. Galatz, Craig M. Ball, Sharlene A. Teefey, William D. Middleton, Ken Yamaguchi - Journal of Bone and Joint Surgery 2004 被引用: 2,146

  6. B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression

    著者: Taito Miyamoto, Ryusuke Murakami, Junzo Hamanishi, Kenji Tanigaki, Yuko Hosoe, Nathan Mise, Shiro Takamatsu, Yuka Mise, Masayo Ukita, Mana Taki, Koji Yamanoi, Naoki Horikawa, Kaoru Abiko, Ken Yamaguchi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai - Cancer Immunology Research 2021 被引用: 153

  7. Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

    著者: Peng Jin, Junzo Hamanishi, Noriomi Matsumura, Kaoru Abiko, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Yuko Hosoe, Susan K. Murphy, Ikuo Konishi, Masaki Mandai - Cancer Research 2015 被引用: 522

  8. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer

    著者: Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato, Tasuku Honjo, Shingo Fujii - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 1,372

  9. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

    著者: Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Tsukasa Baba, Ken Yamaguchi, Yumiko Yoshioka, Masafumi Koshiyama, Ikuo Konishi - Clinical Cancer Research 2016 被引用: 280

  10. VISTA expressed in tumour cells regulates T cell function

    著者: Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Ryusuke Murakami, Mana Taki, Budiman Kharma, Xiang Zeng, Yuko Hosoe, Miyuki Azuma, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2018 被引用: 205

  11. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

    著者: Mana Taki, Kaoru Abiko, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Koji Yamanoi, Naoki Horikawa, Yuko Hosoe, Eijiro Nakamura, Aiko Sugiyama, Masaki Mandai, Ikuo Konishi, Noriomi Matsumura - Nature Communications 2018 被引用: 309

  12. THE DEMOGRAPHIC AND MORPHOLOGICAL FEATURES OF ROTATOR CUFF DISEASE

    著者: Ken Yamaguchi, Κωνσταντίνος Δίτσιος, William D. Middleton, Charles F. Hildebolt, Leesa M. Galatz, Sharlene A. Teefey - Journal of Bone and Joint Surgery 2006 被引用: 902

  13. Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress

    著者: Ken Yamaguchi, Masaki Mandai, Shinya Toyokuni, Junzo Hamanishi, Toshihiro Higuchi, Kenji Takakura, Shingo Fujii - Clinical Cancer Research 2008 被引用: 322

  14. A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer

    著者: Akira Iizuka, Chizu Nonomura, Tadashi Ashizawa, Ryota Kondou, Keiichi Ohshima, Takashi Sugino, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Kouji Maruyama, Ken Yamaguchi, Yasuto Akiyama - Clinical Cancer Research 2019 被引用: 76

  15. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer

    著者: Meng Qin, Junzo Hamanishi, Masayo Ukita, Koji Yamanoi, Shiro Takamatsu, Kaoru Abiko, Ryusuke Murakami, Taito Miyamoto, Haruka Suzuki, Akihiko Ueda, Yuko Hosoe, Akihito Horie, Ken Yamaguchi, Masaki Mandai - Cancer Immunology Immunotherapy 2021 被引用: 48

  16. Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

    著者: Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Mana Taki, Masayo Ukita, Yuko Hosoe, Masafumi Koshiyama, Ikuo Konishi, Masaki Mandai - British Journal of Cancer 2020 被引用: 91

  17. Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line

    著者: Keiichi Ohshima, Kanako Inoue, A Fujiwara, Keiichi Hatakeyama, Kaori Kanto, Yuko Watanabe, Koji Muramatsu, Yorikane Fukuda, Shun‐ichiro Ogura, Ken Yamaguchi, Tohru Mochizuki - PLoS ONE 2010 被引用: 578

  18. PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction

    著者: Kaoru Abiko, Masaki Mandai, Junzo Hamanishi, Yumiko Yoshioka, Noriomi Matsumura, Tsukasa Baba, Ken Yamaguchi, Ryusuke Murakami, Ayaka Yamamoto, Budiman Kharma, Kenzo Kosaka, Ikuo Konishi - Clinical Cancer Research 2013 被引用: 233

  19. Natural history of asymptomatic rotator cuff tears: A longitudinal analysis of asymptomatic tears detected sonographically

    著者: Ken Yamaguchi, A. Marc Tetro, Oren Blam, Bradley Evanoff, Sharlene A. Teefey, William D. Middleton - Journal of Shoulder and Elbow Surgery 2001 被引用: 637

  20. A Prospective Evaluation of Survivorship of Asymptomatic Degenerative Rotator Cuff Tears

    著者: Jay D. Keener, Leesa M. Galatz, Sharlene A. Teefey, William D. Middleton, Karen Steger-May, Georgia Stobbs-Cucchi, Rebecca Patton, Ken Yamaguchi - Journal of Bone and Joint Surgery 2015 被引用: 237

  21. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

    著者: Kui Li, Masaki Mandai, Junzo Hamanishi, Noriomi Matsumura, Ayako Suzuki, Haruhiko Yagi, Ken Yamaguchi, Tsukasa Baba, Shingo Fujii, Ikuo Konishi - Cancer Immunology Immunotherapy 2008 被引用: 174

  22. Symptomatic Progression of Asymptomatic Rotator Cuff Tears

    著者: Nathan A. Mall, H. Mike Kim, Jay D. Keener, Karen Steger-May, Sharlene A. Teefey, William D. Middleton, Georgia Stobbs, Ken Yamaguchi - Journal of Bone and Joint Surgery 2010 被引用: 363

  23. Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks

    著者: Ryusuke Murakami, Noriomi Matsumura, J.B. Brown, Koichiro Higasa, Takanobu Tsutsumi, Mayumi Kamada, Hisham Abou-Taleb, Yuko Hosoe, Sachiko Kitamura, Ken Yamaguchi, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masafumi Koshiyama, Yasushi Okuno, Ryo Yamada, Fumihiko Matsuda, Ikuo Konishi, Masaki Mandai - American Journal Of Pathology 2017 被引用: 137

  24. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types

    著者: Shiro Takamatsu, J. Brown, Ken Yamaguchi, Junzo Hamanishi, Koji Yamanoi, Hisamitsu Takaya, Tomoko Kaneyasu, Seiichi Mori, Masaki Mandai, Noriomi Matsumura - JCO Precision Oncology 2022 被引用: 48